Benzodiazepines (BDZs) are anxiolytic drugs that impair memory acquisition. Previous studies using the plusmaze discriminative avoidance task (PMDAT, which assesses memory and anxiety concomitantly) indicated that the effects of BDZs on anxiety and acquisition are related to each other. The possible influence of the anxiolytic action of BDZs on their effects on memory retrieval and extinction are poorly understood. This is relevant considering the relationship between aversive memories and anxiety disorders. We designed a modified protocol of PMDAT that evaluates anxiety during retrieval and extinction of the task. Male Wistar rats were trained in the PMDAT (plus-maze with two open and two enclosed arms) using a standard or a modified protocol. In the standard protocol, the aversive stimuli were presented in one of the enclosed arms during training, and the animal had free access to the whole apparatus. In the modified protocol, the open arms were blocked with glass walls. Twenty-four hours after training, the animals subjected to each of the protocols were treated with saline or 2.0 mg/kg of diazepam (DZP) 30 min before the test. There was a third session in the maze (retest) 24 h after the test. During the test, DZP impaired and improved retrieval in rats that had been trained in the standard and the modified protocol when compared to the respective saline-treated groups. In addition, treatment with DZP prior to the test induced anxiolysis, but only in the animals that were not pre-exposed to the open arms of the apparatus (modified protocol). In these animals, DZP impaired extinction, which was evaluated during retest session. The impairing effect of DZP on extinction seems to be related to its anxiolytic action during the test (extinction learning). Further, we suggest that aversive memory retrieval depends on both the treatment and the arousal elicited by exposure to the apparatus.
Introduction
Some anxiety disorders, such as post-traumatic stress disorder (PTSD), panic disorder and phobias, involve some extent of maladaptive mnemonic features (Ferreri et al., 2011; Milad et al., 2006; Rubin et al., 2008) . In these disorders, a trigger stimulus, which might be conscious or unconscious, associated to a past traumatic episode -evokes an abnormal and/or excessive anxiety response (American Psychiatric Association, 2013) . Indeed, even generalized anxiety disorder patients presents underlying negative implicit associations with neutral or negative attributes (Reinecke et al., 2010) . Thus, understanding the relationship between aversive memories and anxiety is imperative to stablish the appropriate therapeutic approach to each anxiety disorder.
Although other pharmacological strategies have emerged to treat such disorders, the benzodiazepines (BDZs) are still widely used for alleviating acute distress symptoms or in combination with other anxiolytics, such as selective serotonin reuptake inhibitors (Bandelow et al., 2008) . However, BDZs impair aversive memory extinction in PTSD patients (Gelpin et al., 1996; Matar et al., 2009; Mellman et al., 2002; Zohar et al., 2011) . Also, memory deficits and cognitive impairment are observed in patients chronically treated with BDZs (CADTH, 2014) .
Studies have shown that BDZs impair memory acquisition in humans and in rodent models (Beracochea, 2006; McNamara and Skelton, 1991; Savić et al., 2005) . However, the effects of BDZs on aversive memory retrieval are poorly understood. Previous literature reports contradictory results, showing that BDZs enhance (File et al., 1999; Obradović et al., 2004) , impair (Borde et al., 1997 (Borde et al., , 1996 or have no effects (Chapouthier and Venault, 2002; Venault et al., 1986 ) on memory retrieval. On the other hand, BDZs have been clearly shown to impair aversive memory extinction (Hart et al., 2009; Matar et al., 2009 ).
Further, most of the studies do not take into consideration that BDZs act on both emotional and mnemonic processes, and the relevance of the anxiolytic effects of BDZs to mnemonic processes is unknown. Indeed, the interaction between these two effects could be relevant to the interpretation of the results in aversive conditioning tasks (Pain et al., 2002; Silva and Frussa-Filho, 2000) . Thus, further research to understand how the anxiolytic effect of BDZ interacts with aversive memory retrieval and extinction is necessary to advance the current knowledge on conditioned fear-related disorders.
The plus-maze discriminative avoidance task (PMDAT) is an adaptation of the conventional elevated plus-maze that has been used to assess anxiety and memory-related behaviors concomitantly (Calzavara et al., 2004; Kameda et al., 2007; Munguba et al., 2011; Ribeiro et al., 2011; Silva and Frussa-Filho, 2000) . During the first trial (training) of this two-trial task, one of the enclosed arms is paired with aversive stimuli every time the animal enters it. The stimuli are light and noise, which are not presented in the second trial (test session). Retrieval of the task is evaluated by comparing the time spent in each enclosed arm (aversive and non-aversive) during the second trial. Amnestic (Patti et al., 2006; Silva et al., 1999) and memory-enhancing (Claro et al., 1999; Silva et al., 1997) manipulations decrease and increase the avoidance of the aversive arm in the test session, respectively. Concomitantly, anxiety-like behavior is evaluated by the time spent in the open arms of the apparatus during the training session (Silva and Frussa-Filho, 2000) . Therefore, the paradigm enables the study of the possible relationships between memory and anxiety. Pre-training administrations of chlordiazepoxide and caffeine in rodents have anxiolytic and anxiogenic effects, respectively, and both manipulations impair learning in this task, suggesting that aversive memory acquisition is dependent on an optimal anxiety level during the conditioning phase (Silva and FrussaFilho, 2000) . Further, previous studies have indicated that the impairment in acquisition induced by BDZs is highly dependent on the presence of their anxiolytic effect during the training in the PMDAT (Calzavara et al., 2004; Silva and Frussa-Filho, 2000) .
One important limitation of the use of PMDAT is that the anxiolytic effect of some pharmacological agents (mainly BDZs) is weakened, or even absent, during the second trial in the apparatus. This is a consequence of the one-trial tolerance (OTT) that is induced by the exposure to the apparatus in the training session (Silva and Frussa-Filho, 2000) . This phenomenon is also described to the conventional elevated plusmaze (EPM), and defined as the loss of the anxiolytic effect of benzodiazepines (BDZs) on rodents previously exposed to the EPM (File, 1990; File et al., 1990) .
The absence of an anxiolytic action of BDZs on rodents pre-exposed to the PMDAT precludes the investigation of possible relationships between the effects of BDZs on anxiety and retrieval or extinction. In this sense, studies support the view that one-trial tolerance depends on the prior exploration of relatively safe areas of the maze and the retention of information from the first trial. Such learning would prevent the presence of novelty, and the loss of BDZ efficacy on the second trial would reflect absence of an approach/avoidance conflict (Bertoglio and Carobrez, 2000; Rodgers and Shepherd, 1993; Roy et al., 2009 ). Therefore, a modification of the original protocol that allows the reliable assessment of anxiety-like behavior during the second exposition in the PMDAT would be useful to the investigation of possible relationships between retrieval/extinction and anxiety.
This investigation is required because the anxiolytic activity of a compound is often measured by the ability to prevent aversive conditioned responses. That is the case of tests such as fear-potentiated startle (Brown et al., 1951; Davis, 1986) , Vogel water-lick conflict (Petersen and Lassen, 1981; Vogel et al., 1971 ) and context-conditioned freezing (Beck and Fibiger, 1995; Fanselow and Helmstetter, 1988; Malkani and Rosen, 2000; Resstel et al., 2006) . These tests do not dissociate innate from learned fear responses, because the same behavioral outcome is expected in both cases. Therefore, a specific activity upon innate fear cannot be dissociated from the impairing effects on conditioned fear responses. An animal model able to address both innate and learned fear responses could be useful to the screening for novel therapeutic agents as well as to the understanding of the pathophysiology of anxiety disorders.
Briefly, the PMDAT address the effects of treatments on both innate and learned fear responses, evaluated by different behavioral outcomes. This dissociation is relevant because these responses rely on different neural pathways (for review, see (Gross and Canteras, 2012) ). Indeed, as demonstrated in the study by Ribeiro et al. (2011) , the inactivation of the basolateral amygdala (BLA) impaired aversive memory acquisition, but not the innate fear response in the PMDAT.
Furthermore, the PMDAT has an ethical advantage compared to other aversive conditioning paradigms. The conditioning in the training session is conducted through the presentation of mild stimuli (i.e. light and noise), while most of other associative learning paradigms comprise painful stimuli (Davis, 1986; Resstel et al., 2006; Vogel et al., 1971) . As well, the nature of the aversive stimuli in the PMDAT is closer to rodent's natural aversive behavioral repertory. That is, strong light and loud noises relate closer to aversive environmental expositions than electrical shocks or other painful stimuli in rodents. Hence, the PMDAT also relates closer to a natural aversive condition in humans, which is a desirable feature to emulate disorders with aversive associations.
The aim of the present study was to verify the effects of the BDZ diazepam (DZP) on aversive memory retrieval and extinction in rats subjected to the PMDAT. In order to evaluate anxiety-related behaviors on the second trial of the PMDAT, we designed a protocol to prevent the occurrence of one-trial tolerance. In the modified protocol, the open arms were blocked with transparent glass walls during the training session, precluding the exploration of these areas of the maze. The test was carried out without protocol modifications, and we added a third session (identical to the test session) at the end of the experiment to assess aversive memory extinction.
Materials and methods

Animals
Three-month-old Wistar male rats (250-300 g) were housed in groups of four in plastic-walled cages (45 × 35 × 15 cm), under controlled temperature (23 ± 1°C) and lighting (12:12 h light-dark cycle; lights on at 6:00 am). The animals had free access to food and water, and were exposed to 5 min of gentle handling for 7 days prior to the experiment. All tests were performed during the light period (1:00 to 5:00 p.m.), and animals were pseudo-randomly assigned to each group in order to include at least one animal of each group per cage.
All procedures were approved by the Committee on Animal Research and Ethics of the Federal University of Rio Grande do Norte and are in accordance with the Brazilian law for animal experimentation (Law 11.794). All efforts were taken to minimize pain, suffering, discomfort, and the number of animals used.
Plus-maze discriminative avoidance task (PMDAT)
The PMDAT was conducted in a modified elevated plus-maze that was made of wood, with two enclosed (50 × 15 × 40 cm) opposing two open (50 × 15 cm) arms. A 100 W lamp and a speaker were placed over one of the enclosed arms (aversive enclosed arm).
The behavioral protocol is schematized in Fig. 1 . The rats were exposed to three trials. During the training session, each rat was placed individually in the center of the apparatus, facing the intersection between the open arms, and allowed 10 min of free exploration. Every time an animal entered with all four paws into the aversive enclosed arm, the 100 W light (1500 lx at the maze floor level) and a digitally produced 80 dB white noise were turned on until the animal left the arm. In this training session, the rats went through the standard or the modified version of the PMDAT. In the modified version, the open arms were blocked with transparent glass walls to prevent exploration ( Fig. 1) , which allowed visual access to spatial cues (window and poster on the wall). The percentage of time that was spent in the aversive enclosed arm (throughout the total duration and 200 s epochs) in the training session was used as a measure of learning. Thus, we expect that an animal that learned the task would reduce its spontaneous visits to the aversive arm throughout training session epochs, and discriminate the enclosed arms in total session data.
The test session was performed 24 h later. All animals were reexposed to the regular apparatus (without the glass walls) for 10 min and the aversive stimuli were no longer presented. The time spent in the aversive enclosed arm during the test was used as a measure of the retrieval of the aversive information.
A third session (retest), identical to the test session, was conducted 24 h later to assess extinction retrieval.
The apparatus was cleaned with a 5% alcohol solution before each behavioral session. The sessions were recorded with a digital camera that was placed above the apparatus. The behavioral sessions were monitored using an animal tracking software (ANY-maze, Stoelting, USA) on a computer screen that was placed in another room.
The time spent in the aversive enclosed arm, the neutral enclosed arm and the open arms (except for the group exposed to the modified plus-maze in the training session) were measured during all sessions. The percentage of time spent in the aversive (%TAV) and open arms (%TOA) were calculated by the formulae (time in aversive arm / time in aversive arm + time in non-aversive arm) * 100 and (time in open arms / time in aversive arm + time in non-aversive arm + time in open arm) * 100, respectively. Memory retention was evaluated by comparing the %TAV versus exploration of enclosed arms (aversive and non-aversive arms) by chance (50%). A poor performance is characterized by exploration of the two enclosed arms at the level of chance (50% for each arm). Therefore, a significant difference from chance represents discrimination of the aversive arm. Anxietylike behavior was evaluated by the percentage of time that was spent in the open arms (%TOA) across the total session as well as in the first 5 min of each session. This time-window analysis was chosen on the basis of previous data showing that 5 min is the appropriate period to evaluate the anxiolytic effects of BDZs in the PMDAT, due to the possibility of acquisition of OTT within a 10-min session (Silva and Frussa-Filho, 2000) . Locomotor activity was measured by the distance traveled in the apparatus.
Drug administration and experimental groups
Diazepam (DZP, Valium®, Roche, Brazil) was dissolved in physiological saline with 2% Tween-80, which was used as control solution. Thirty minutes before the test session (see Section 2.2), animals that have been exposed to either the standard (STD) or modified (MOD) protocol (in the training) received saline (STD/SAL = 12 and MOD/SAL = 12) or 2 mg/kg of DZP (STD/DZP = 10 and MOD/DZP = 10) intraperitoneally (i.p.), in a volume of 1 ml/kg of body weight (Fig. 1) . Previous studies have demonstrated the anxiolytic action of this dose in the conventional elevated plus-maze (Almeida et al., 1991; Guimarães et al., 1990; Taukulis and Goggin, 1990 ). In addition, we have recently conducted a dose-response curve of DZP in the PMDAT as part of another study (Silva et al., unpublished data) . We found that DZP presents anxiolytic action in this paradigm when given at 2 and 4 mg/kg, but not 1 mg/kg.
Statistical analysis
Data normality and the homogeneity of variances were tested by Kolmogorov-Smirnov and Levene's tests, respectively. Comparisons between the percentage of time that was spent in the aversive enclosed arm (%TAV) and exploration of the enclosed arms by chance (50%) were conducted with one-sample t-tests to determine whether the animals discriminated aversive arm. Bonferroni correction was applied to reduce type I error due to multiple comparisons; therefore, the significance level was set at p b 0.0125 for this analysis. Comparisons between groups to all parameters were performed by a two-way analysis of variance (ANOVA) with the type of protocol and treatment as betweensubjects factors, or a three-way ANOVA with repeated measures with time epochs throughout session as within factor and type of protocol and treatment as between factor. A post-hoc comparison with Sidak's test was conducted to detect differences in the magnitude of the effects. Independent sample t-tests were applied to yield differences between groups to total distance traveled and %TOA data during training session. Significance level was set at p b 0.05. All statistical analyses were conducted with PASW Statistics 18 software (IBM, USA).
Results
3.1. Learning and memory: aversive enclosed arm exploration 3.1.1. Training session: acquisition One-sample t-tests on the total session data with the test value set to 50% (i.e., exploration of the aversive arm by chance) and Bonferroni correction for multiple comparisons revealed that all groups learned the task [STD/SAL: t(12) = 113.14; STD/DZP: t(10) = 94.79; MOD/SAL t(12) = 136.04; MOD/DZP: t(10) = 70.80; p b 0.001]. Accordingly, two-way ANOVA to total session did not find significant differences ( Fig. 2A) . A three-way ANOVA with repeated measures to time epochs throughout the session revealed no significant effect of the type of protocol, treatment group or interactions, only a significant effect of time (Fig. 2B) . 
Test session: retrieval
One-sample t-tests on the total session data revealed that all groups discriminated the aversive arm [STD/SAL: t(12) = 19.28; STD/DZP: t(10) = 5.40; MOD/SAL t(12) = 9.20; MOD/DZP: t(10) = 13.54; p b 0.001], which indicates that all groups retrieved the aversive memory (Fig. 1A) . However, a two-way ANOVA to total session revealed a significant interaction between treatment and type of protocol [F(1,44) = 12.269; p = 0.001]. A post-hoc comparison using Sidak's test revealed that both the STD/SAL and MOD/DZP groups spent less time in the aversive arm compared with the STD/DZP and MOD/SAL groups (p b 0.05) ( Fig. 2A) . These results indicate that DZP treatment improved aversive memory retrieval in the MOD protocol, but impaired retrieval in rats trained in the STD protocol. This finding was confirmed by a threeway ANOVA with repeated measures to time epochs throughout the session, which revealed a significant interaction between time epochs and type of protocol [F(2,80) = 915.329, p = 0.034] and between type of protocol and treatment [F(1,40) = 11.300, p = 0.002] (Fig. 2C ). Sidak's post-hoc test to the interaction between type of protocol and time epoch revealed that only STD group extinguished aversive memory throughout test session, as indicated by comparisons between 0 and 200 s epoch to 200-400 s (p = 0.05) and 400-600 s (p = 0.019). In Fig. 2C , it is clear that STD groups exhibited reduction in the avoidance response to the aversive arm throughout the session compared to MOD groups.
Retest session: extinction
One-sample t-tests on the total session data (with test value as 50%) with Bonferroni correction applied for multiple comparisons revealed that only the MOD/DZP group discriminated the aversive arm [MOD/ DZP: t(10) = 11.93, p b 0.001], which indicates that DZP treatment impaired aversive memory extinction in rats trained in the MOD protocol. Neither a two-way ANOVA to total session nor a three-way ANOVA with repeated measures to time epochs throughout session revealed significant differences (Fig. 2A,D) .
Anxiety: percentage of time in the open arms
In the training session, independent sample t-test to STD groupswhich had access to the open arms -found no effects for %TOA in neither of the time windows analyzed (first 5 min and 10 min of session).
In the test session, a two-way ANOVA for the %TOA during the first 5 min of the session revealed significant effects of type of protocol (MOD vs. STD) [F(1,44) = 13.448, p = 0.001] and the interaction between the type of protocol and treatment [F(1,44) = 3.864, p = 0.056]. Sidak's post-hoc test (p b 0.05) revealed differences to MOD/ DZP group compared to all other groups in the first 5 min of session (Fig. 3A) , which indicates that on the STD protocol rats developed the one-trial tolerance to the anxiolytic effect of DZP. Simply put, only animals submitted to the MOD protocol presented the proper anxiolytic response to DZP, which indicates that OTT was prevented by the maze modification and that previous open arms experience indeed reduces approach towards open arms (Fig. 3A) . Thus, the MOD protocol prevented the OTT phenomenon in the first 5 min of test session. Furthermore, data from the 10 min of session suggests that OTT was acquired throughout the test session.
In the retest session, two-way ANOVAs on the %TOA during the first 5 and the whole 10 min of the session revealed significant effects of the treatment only in the 5 min of session [F(1,44) = 4.290; p = 0.045], with SAL groups spending more time in the open arms than DZP groups. Sidak's post-hoc test did not yield any differences between groups.
Motor activity: distance traveled in the apparatus
Independent t-tests to total distance traveled for the training session showed no significant difference of the type of protocol in male rats, despite reduced area to explore in the MOD protocol compared to the STD protocol. A two-way ANOVA to the same variable to test and retest session also did not find any effect (Table 1) . 
Correlation between anxiety and memory parameters
Pearson's correlation test was applied for the %TAV scores during the test or retest session versus the %TOA scores during the 5 or 10 min of the test session to detect whether an interaction exists between anxiety and memory parameters. Results showed only a weak positive correlation between %TAV during the test session versus %TOA in the entire 10 min of the test session (p b 0.05, r = 0.29; Table 2 ). Therefore, the exploration of the open arms during the test session appears to have little or no influence on the exploration upon the aversive arm during the test and retest sessions.
Discussion
In this study, we found that animals learned the task properly irrespective of the type of protocol, as shown by both the total session and time epochs during the training session ( Fig. 2A,B) . Accordingly, differences to motor activity due to reduced area of the apparatus in the modified protocol was not a major issue to exploratory behavior in the training session (Table 1) . Moreover, as expected due to absence of DZP treatment, no differences were found to percent time in open arms to groups in the standard protocol (Fig. 3A,B) .
Data of the test session revealed that all groups retrieved the task, which was measured by the ability to discriminate the aversive enclosed arm during the test session ( Fig. 2A, one-sample t-test) . However, the magnitude of the retrieval varied between groups. We found an interaction between type of protocol and treatment. Namely, DZPtreated animals that trained in the standard and modified protocols exhibited higher and lower retrieval magnitudes, respectively, when compared with their respective controls ( Fig. 2A) . Additionally, MOD/ SAL group performed worse than STD/SAL group. Thus, change in the protocol seemed to reduce discrimination between the enclosed arms in the task. Furthermore, only animals that underwent training in the standard protocol exhibited extinction behavior throughout the test session (Fig. 2C) .
The evaluation of anxiety during the test session revealed that the type of protocol had influence in open arm exploration, with animals under the modified protocol spending more time in the open arms. Further, the anxiolytic effect of DZP was expressed only under the modified protocol (Fig. 3A) . Indeed, DZP was ineffective in modifying the exploration of the open arms in rats trained under the standard protocol of the PMDAT. This result (absence of the anxiolytic effect of DZP) was expected due to the OTT phenomenon. Conversely, DZP-treated animals submitted to the modified protocol exhibited higher rates of open-arms exploration in the first 5 min of the test session when compared to all other groups (Fig. 3A) . Thus, preventing the exploration of the open arms -but keeping the visuospatial cues and the configuration of the apparatus -leads to the maintenance of the approach/avoidance conflict and eliminates the OTT to the anxiolytic effect of DZP. In addition, the analysis of the data from the entire 10-min session (Fig. 3B) revealed that all groups explored the open arms similarly. This results demonstrates the occurrence of one-trial tolerance to the effects of diazepam within the session, which corroborates a previous report by Silva and Frussa-Filho (2000) .
Briefly, saline-treated animals performed better after being trained in the standard protocol compared with the modified protocol, while DZP-treated animals trained under the modified protocol performed similarly to the saline-treated animals trained under the standard protocol. Taken together, the findings for aversive memory in the test session may be related to the influence of the optimal level of anxiety that is necessary to retrieve the task. Prior studies have suggested that optimal levels of anxiety are required for adequate performance on the PMDAT (Calzavara et al., 2004; Silva and Frussa-Filho, 2000) , as well as in other aversive and working memory tasks (Calabrese, 2008; Diamond et al., 2007; Mair et al., 2011) . These findings could explain the apparent contradictory effects of DZP on memory retrieval. In other words, the absence of the approach/avoidance conflict during the test session in the standard protocol might result in a downward shift in general arousal. This view is corroborated by the fact that rats exposed to the EPM presents crossed one-trial-tolerance to the light/ dark box (Rodgers and Shepherd, 1993) and antinociception (Lee and Rodgers, 1990) . A reduction in arousal could be potentiated by BDZs, which would lead to a suboptimal anxiety level to perform the task. Therefore, the presence of the approach/avoidance conflict during the test session of rats trained under the modified protocol may preserve the arousal that is elicited by the apparatus. In addition, the anxiolytic manipulation during the test session may have improved the 
Table 1
Total distance traveled in the whole apparatus (mean ± SEM) during all experimental sessions displayed by rats submitted to standard (STD) or modified (MOD) training protocols and treated with saline (SAL) or 2 mg/kg diazepam (DZP) 30 min prior to the test session. Data are expressed as mean ± SEM (independent sample t-tests). performance of the animals by reducing arousal to a closer optimal level of anxiety to perform the task. Collectively, these findings illustrates the inverse U-shaped optimal arousal curve by Yerkes and Dodson (Yerkes and Dodson, 1908) . That is, DZP impaired the performance of animals that were trained in the standard protocol by decreasing anxiety bellow the optimum level. At the same time, the impairment in aversive memory retrieval induced by the modified protocol was restored by DZP administration. This phenomenon supports the view that the type of protocol and the treatment act as opposing agents on the optimal arousal level to aversive memory retrieval. Nevertheless, few studies have investigated the interaction of arousal with BDZs action on memory retrieval and anxiety in humans. For instance, studies in humans reports that the effects of the BDZ lorazepam on memory are dose-dependent. That is, lorazepam impairs emotional and episodic memory retrieval in doses higher than 1.5 mg/kg, but facilitates memory retrieval when given at the 1.0 mg/kg dosage (Brignell et al., 2007; File et al., 1999) , which suggests a similar pattern of optimal level of arousal to perform a memory task.
An alternative interpretation suggests that the increase in the exploration of the open arms influenced the aversive arm exploration. However, only a weak positive correlation (r b 0.3) was detected between %TAV and %TOA in the test session (Table 2 ). In addition, the %TOA data across the total session shows that the exploration of the open arms did not exceed 20% of the total time in the apparatus. As well, no differences to total distance traveled were found for the test session. Therefore, it seems unlikely that an increase in the exploration of the open arms during the initial 5 min and/or motor activity in the test session account for the reduced exploration of the aversive arm.
The analysis of the retest session revealed that animals extinguished the aversive task, except for the DZP-treated animals that were trained in the modified protocol. These animals continued to avoid the aversive arm during the retest session ( Fig. 2A) . Previous studies have shown that the administration of BDZ before the extinction learning (test session in this study) blocks extinction (Bouton et al., 1990; Hart et al., 2009) . As mentioned, this could be of relevance in the context of treatment of anxiety disorders related to aversive learning with BDZ. Arousal is associated with activation of the hypothalamic-pituitary-adrenal (HPA) axis, and consequently with secretion of glucocorticoids. This response is instrumental to adaptation to stress and is involved in the installment of phobic fear. Subjects who received cortisol 1 h before exposure to phobic stimuli reported reduced fear (Soravia et al., 2006) . In contrast, BDZs reduces the activation of HPA axis and lower the level of glucocorticoids after stress exposure (Matar et al., 2009) . That is, the disruption of this physiological coping mechanism might be on the foundation of PTSD pathophysiology. In fact, chronic BDZ therapy after traumatic events has been shown to facilitate PTSD installment (Gelpin et al., 1996) or impair extinction learning in PTSD patients (Rothbaum et al., 2014) . Similarly, in an animal model of PTSD, administration of alprazolam 1 h after aversive stimuli exposition was associated with increased fear response compared to controls (Matar et al., 2009 ). In accordance, we found that the administration of DZP under an arousing context (i.e. exposition to the complete apparatus after training in the modified protocol) could disrupt HPA axis response and impair aversive memory extinction. Conversely, a less arousing context (i.e. exposition to the standard protocol) would not result in impaired aversive memory extinction.
Alternatively, the phenomenon of state dependency could explain the effects of DZP on extinction learning. For example, Bouton et al. (1990) described that fear extinction is state-dependent to the effects of DZP in a dose-dependent manner. This hypothesis holds that drugrelated cues are part of the context under which extinction learning occurs. Therefore, the absence of the cues on a subsequent test could result in a failure to retrieve the extinction memory. This failure is an example of the renewal phenomenon, in which the shift of context between extinction learning and retrieval restores fear responses (Bouton and King, 1983; Bouton and Ricker, 1994; Harris et al., 2000) . In this context, the anxiolytic effect of DZP during the test session may represent the drug-related cue during extinction learning in test session. Subsequently, the absence of the drug-related cue in retest session could have restored the avoidance response to the aversive arm. Neverthelessbased on the findings for anxiety parameters -if the extinction deficit was due to state dependency, one would expect that the STD-DZP group did not extinguish aversive memory in the retest session as well. Thus, it is questionable that the state-dependency phenomenon account for the observed effect on aversive memory.
Finally, a possible explanation to this outcome is that the drug disrupted the learning process that underlies extinction. A mechanism by which the drug may have disrupted this learning is through the reduction in the levels of activity in the fear system. Contemporary models propose that the inhibitory learning that occurs in extinction is regulated by the discrepancy between the fear elicited by the conditioned stimulus and the absence of fear elicited by the new situation (no aversive stimulus) (Osan et al., 2011) . Therefore, reducing the levels of activity in the fear system through the systemic administration of DZP would reduce the discrepancy and impair the development of extinction learning. This view is supported by findings that have been obtained with intra-BLA inactivation with midazolam, muscimol, 2-amino-5-phosphonopentanoic acid (APV) or bupivacaine (Hart et al., 2009; Kim and Richardson, 2008; . The administration of each of these drugs impaired extinction when infused before the extinction learning session. In addition, BLA activity has been implicated in aversive memory acquisition on the PMDAT Ribeiro et al., 2011) . Once more, in view of the exposed rationale, one would expected that DZP treatment would impair aversive memory extinction to both DZP-treated groups.
The aforementioned views are rather additive than mutually exclusive. All rationales are supported by the anxiety parameters that were observed in the test session -only the animals that displayed DZPinduced anxiolytic activity failed to exhibit extinction during the retest session. In contrast to previous reports, the present study includes an evaluation of anxiety levels concomitant to the evaluation of retrieval, which dissociates the confounding factor of anxiety that is present in most of the fear conditioning models.
Of notice, sedation has been indicated as an important confounding factor in memory and anxiety models that are based on conditioned responses (Hart et al., 2009; Resstel et al., 2006) . Differently from most studies, we also controlled for the motor behavior effects of DZP or type of protocol manipulations. In the present study, we demonstrated that neither the dose of DZP used in the study (2.0 mg/kg) nor the type of protocol induced differences in motor activity during the test and retest sessions (Table 1) . Thus, the evaluation of motor activity during test and retest session suggests that neither sedation nor the reduction of motivation to explore the apparatus were critical issues in this study. Nonetheless, although not statistically significant, there was an increase in the distance traveled of MOD/SAL compared to the STD/SAL in test session (Table 1) . This finding might be due to the novel area available for exploration by animals in the MOD/SAL group (which were trained with partial blocking of the maze) compared to the STD/SAL groupwhich was formerly habituated to the whole apparatus.
In short, data reported in the present study demonstrated that the anxiolytic activity of DZP is critically important to the impairment of extinction learning caused by this BDZ, but not to the aversive memory retrieval. This retrieval seems to depend on an optimal anxiety level. In view of the aforementioned results, the use of BDZs as a pharmacological treatment of conditioned fear-related disorders should be carefully reconsidered due to its potential impairing effect on aversive memory extinction.
Nevertheless, further investigation is required to address the speculative reasoning raised along the discussion. For instance, it would be relevant to address the action of other classes of drugs -such as antidepressants or other anxiolytics, as well a possible role of statedependent learning under the protocol used here. Further, it would be also important to determine corticosterone levels in other to investigate the role of the HPA axis on aversive memory extinction.
Finally, we introduce a modified version of the PMDAT. This modification allows the evaluation of anxiety and retrieval/extinction of aversive memory in the test and retest sessions to enable correlational inferences between these variables. These features highlight the PMDAT as a valuable model to study the interactions of learned and innate fear components, which are imperative to understanding anxiety disorders that comprise mnemonic components.
